75000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONDENSED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - CONDENSED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Financings link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Net Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Joint Venture link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Organization (Policies) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Net earnings per share (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Financings - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Net Earnings Per Share - Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Net Earnings Per Share - Schedule of Net Loss Attributable to Common Shareholders (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Stock-Based Compensation - Share-Based Compensation Expense on All Employee and Non-Employee Awards (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Stock-Based Compensation - Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Stock-Based Compensation - Stock Option Activity Under Stock Option Plan (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Warrants - Summary of Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Joint Venture - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Additional loans committed. Additional Loans Committed Additional Loans Committed Clinical expenses. Clinical Expenses Clinical expenses Stock Issued During Period, Shares, Issued as consideration for services Stock issued during period shares issued as consideration for services Shares issued as consideration for services (in shares) Entity Incorporation, State or Country Code Shares sold Preferred Stock, Shares Issued Preferred stock, shares issued Statement of Financial Position Location, Balance [Domain] Balance Sheet Location [Domain] Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Long-term debt Long-Term Debt, Excluding Current Maturities Long-term debt Debt obligations Two thousand and twenty equity incentive plan [Member]. Two Thousand And Twenty Equity Incentive Plan [Member] 2020 Equity Incentive Plan [Member] Plan Name [Axis] Plan Name [Axis] Equity [Abstract] Entity Current Reporting Status Fully drawn amount Fully Drawn Amount Fully drawn amount. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common stock, shares authorized Product and Service [Axis] Document Fiscal Period Focus Entity Shell Company Equity Incentive Plan Amendment [Policy Text Block] Equity incentive plan amendment. Equity Incentive Plan Amendment Class of Warrant or Right, Weighted- Average Exercise Price Granted Class of warrant or right, weighted- average exercise price granted. Weighted- Average Exercise Price, Granted Cash and Cash Equivalent Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash balance Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Statement [Table] Statement [Table] Class of Warrant or Right, Forfeited Class of warrant or right, forfeited. Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value Increase (Decrease) in Receivables Increase (Decrease) in Receivables, Total Receivables Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Beginning Balance Stock option purchase of common stock exercise price Statement [Line Items] Statement [Line Items] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] WatermillAndRobertWPostmaMember Watermill And Robert W Postma [Member] Watermill And Robert W Postma. Warrant [Member] Warrants [Member] Entity Filer Category Debt Instrument Redemption Period Two Member Debt Instrument, Redemption, Period Two [Member] Liabilities and Equity Total liabilities and stockholders' equity Debt Instrument [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Options exercisable, at end of period Long-Lived Tangible Asset [Axis] Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses and Other Current Assets [Member] Deferred Revenue [Domain] Proceeds from collateral account Proceeds from Issuance of Debt Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Extinguishment of Debt, Amount Extinguishment of debt, amount Shares Issued, Price Per Share Shares price, per share Subsequent Event [Line Items] Pre Funded Warrants [Member] Pre funded warrants. Pre Funded Warrants Other long-term assets Prepaid Expense and Other Assets, Noncurrent Prepaid expenses and other assets, non current Additional Paid in Capital, Common Stock Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional paid-in capital Debt Issuance Costs, Net Issuance costs Debt Issuance Costs, Net, Total Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Vesting [Domain] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Net Loss Attributable to Common Shareholders Investment, Name [Axis] Earnings Per Share, Basic, Total Earnings Per Share, Basic Earnings per share, Basic Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Ending Balance Beginning Balance Outstanding options issued Stock option, outstanding Salary and Wage, Officer, Excluding Cost of Good and Service Sold Annual base salary Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Subscription Agreement Subscription Arrangement [Member] Stockholders' equity Equity, Attributable to Parent [Abstract] Entity Small Business Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Accrued Liabilities, Total Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated deficit Preferred Stock Preferred Stock [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Cancelled Tenth Scheduled Payment Member Tenth Scheduled Payment [Member] Tenth Scheduled Payment. Sale Of Series A One Preferred Stock Shares Sale of series a one preferred stock shares. Sale of Series A-1 preferred stock (in shares) Financing Arrangements Disclosure [Text Block] Financings Includes disclosures related to financing receivables and financing guarantees in which the company is the guarantor. Amendment Flag Product and Service [Domain] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants Warrants to purchase common stock Chief Executive Officer Chief Executive Officer [Member] Chief Executive Officer [Member] Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Entity Address, Postal Zip Code Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash flows from operating activities Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Common Stock [Member] Common Stock Common Stock [Member] Deferred Board Service Fees Deferred board service fees . Deferred board service fee Class of Warrants or Right Exercised Class of warrants or right exercised. Number Of share Exercised Eden Biocell [Member] Eden Biocell. Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model Fair Value Hierarchy and NAV [Axis] Fair Value, Hierarchy [Axis] Earnings Per Share [Abstract] Statement of Financial Position Location, Balance [Axis] Balance Sheet Location [Axis] Debt Instrument, Redemption, Period [Axis] Class of Warrant or Right [Axis] Document Type Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Arrangements and Non-arrangement Transactions [Domain] Entity Central Index Key Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net decrease in cash, cash equivalents Subsequent Event Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities excluded from computation of earnings per share, amount Common Stock, Par or Stated Value Per Share Common stock, par value Share Subscription Agreement Share Subscription Agreement [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding, period Administrative Fees Expense Strategic and advisory services fee Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, Maximum Non Vested Stock [Member] Non Vested Stock [Member] Unvested Stock [Member] Debt Disclosure [Abstract] Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Fair Value Measurements Accrued expenses Accrued Liabilities, Current Accrued Liabilities, Current, Total Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Document Quarterly Report Preferred Stock, Amount of Preferred Dividends in Arrears Undeclared cumulative dividends Entity Address, State or Province Investment, Name [Domain] Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Common Stock, Capital Shares Reserved for Future Issuance Common stock reserved for future issuance Class of Warrant or Right [Domain] Line of Credit Facility, Lender [Domain] Term B Tranche. Term B Tranche [Member] Term B Tranche [Member] Series A Two Preferred Stock [Member] Series A-2 Preferred Stock Series A two preferred stock. Series A-2 Preferred Stock [Member] Preferred Stock, Redemption Price Per Share Preferred stock price per share Sale of Series A-1 preferred stock Sale Of Series A One Preferred Stock Value Sale of series a one preferred stock value. Subsequent Event [Member] Subsequent Event [Member] Subsequent Event Securities Purchase Agreement. Securities Purchase Agreement [Member] Securities Purchase Agreement Deferred Revenue Arrangement Type [Axis] Stock Options and Restricted Stock Awards Stock Options and Restricted Stock Awards [Text Block] Stock-Based Compensation Antidilutive Securities [Axis] Antidilutive Securities [Axis] Subsidiary or Equity Method Investee [Line Items] Interest Expense, Debt Interest expense Interest Expense, Debt, Total Sale Of Series A Two Preferred Stock Shares Sale of series a two preferred stock shares. Sale of Series A-2 preferred stock (in shares) Line of Credit Facility, Frequency of Payment and Payment Terms Description of payment terms Preferred stock value Preferred Stock, Value, Issued Loss Contingency Accrual, Payments Contingency accrual, payments Eighth Scheduled Payment Eighth Scheduled Payment. Eighth Scheduled Payment [Member] Minimum [Member] Minimum [Member] Financial Instrument [Axis] Assets, Current [Abstract] Current assets: Common Stock Issued for Services Rendered Common stock issued for services rendered. Common stock issued for services rendered Payments to Fund Long-Term Loans to Related Parties Payments to Fund Long-term Loans to Related Parties Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of warrants issued Convertible Preferred Stock Purchase Price Convertible preferred stock purchase price. Convertible preferred stock aggregate purchase price Segment Reporting [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Assets and Liabilities Measured at Fair Value on Recurring Basis Liabilities, Current [Abstract] Current liabilities: Related Party Transactions [Abstract] Shares, Outstanding Balance (in shares) Balance (in shares) Commitments and Contingencies Commitments and contingencies (Note 4) General and Administrative Expense [Member] General and Administrative [Member] General and Administrative [Member] Debt Instrument, Basis Spread on Variable Rate Line of credit facility, interest rate Preferred Stock, Dividend Rate, Percentage Percentage of preferred stock dividends payablein shares Increase in Authorized Shares [Policy Text Block] Increase in authorized shares. Increase in Authorized Shares Series A-2 Preferred Stock [Member] Series A-2 preferred stock. Series A - 2 Preferred Stock [Member] Related party transaction expenses from transactions with related party advisory fees. Related Party Transaction Expenses From Transactions With Related Party Advisory Fees Minimum Required Amount of Stockholder Equity Minimum required amount of stockholder equity. Minimum required amount of stockholder equity Text Block [Abstract] Debt instrument, initial maturity date Debt Instrument, Maturity Date Range, Start Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding, basic Warrants Disclosure [Abstract] Warrants Disclosure Abstract Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Options exercisable, at end of period Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Long-Lived Tangible Asset [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Stock options, granted Subsequent Events [Text Block] Subsequent Events Related Party Transactions Disclosure [Text Block] Related Party Transactions Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member] Fair Value, Inputs, Level 2, and Level 3 [Member] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Balance Equity, Attributable to Parent Balance Total stockholders' equity Total stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock par value or stated value Preferred stock, par value Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Tri Arm Tri Arm [Member] TriArm [Member] Statement of Stockholders' Equity [Abstract] Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Nonvested Share Activity [Table Text Block] Summary of Unvested Restricted Stock Collaborative Arrangement [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Entity Address, Address Line Two Prepayment premium percentage Percentage of prepayment premium Percentage of prepayment premium Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Share-Based Compensation Expense on All Employee and Non-Employee Awards Pocket expenses Pocket Expenses Pocket expenses. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Debt Instrument, Name [Domain] Debt Instrument, Periodic Payment Debt instrument, periodic payment Debt Instrument, Periodic Payment, Total Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Plan Name [Domain] Plan Name [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Entity [Domain] Entity [Domain] Credit Facility [Axis] Equity Method Investment, Ownership Percentage Equity interest in affilated entity Organization Business Description and Basis of Presentation [Text Block] Business Dune Lake Capital Dune Lake Capital [Member] Class of Warrant or Right, Outstanding Number of Shares, Beginning Balance Number of Shares, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Weighted Average Contractual Term (Years) Related and Nonrelated Parties [Axis] Related Party [Axis] Entity Address, City or Town Percentage of commission on gross proceeds from sale of common stock Percentage Of Commission On Gross Proceeds From Sale Of Common Stock Sales commission as a percentage of gross proceeds Security Exchange Name Credit Facility [Domain] Employee Benefit and Share-Based Payment Arrangement, Noncash Employee Benefit and Share-based Payment Arrangement, Noncash, Total Stock-based compensation Milestone payments maximum amount. Milestone Payments, Maximum Amount Milestone maximum payment Board of Directors [Member] Board of directors. Board of Directors [Member] Fair Value, Net Asset (Liability), Total Fair Value, Net Asset (Liability) Fair value of assets (liabilities) Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Term B Milestone [Member] Term B Milestone [Member] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, cash equivalents and restricted cash Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Statistical Measurement [Domain] Range [Domain] Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant exercise per share Weighted- Average Exercise Price Assets, Current Total current assets Document Period End Date Sale of stock during period Stock offered during period shares. Stock Offered During Period Shares Stock issued during period Equity Method Investments and Joint Ventures [Abstract] Title and Position [Axis] Title of Individual [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy [Domain] Options exercisable, at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Debt Instrument, Description of Variable Rate Basis Debt instrument description of variable rate basis Statement of Financial Position [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Vesting [Axis] Class of Stock [Axis] Class of Stock [Axis] Warrants and Rights Outstanding, Maturity Date Warrant expiry date Liabilities Total liabilities Operating Costs and Expenses [Abstract] Operating expenses: Financial Instruments [Domain] The University Of Texas M D Anderson Cancer Center And The Texas A And M University System The University Of Texas M D Anderson Cancer Center And The Texas A And M University System [Member] The University of Texas MD Anderson Cancer Center and The Texas A & M University System [Member] Payment under license agreement Payment Under License Agreement Payment under license agreement. Warrants issued Debt Conversion, Converted Instrument, Warrants or Options Issued Restricted cash related to the Company's debt agreement Restricted cash Restricted Cash Restricted Cash, Total Class of Warrant or Right, Weighted- Average Exercise Price Exercised Class of warrant or right, weighted- average exercise price exercised. Weighted- Average Exercise Price, Exercised Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding, diluted Securities Act File Number Entity File Number Class of Warrants or Right Granted Class of warrants or right granted. Number of Share Granted Cover [Abstract] Expected volatility, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Additional Paid In Capital Additional Paid in Capital, Common Stock [Member] Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets, current Amount Of Prepayments Premium Amount Of Prepayments Premium. Amount of prepayments premium Related Party Transaction Reimbursed Amount. Related Party Transaction Reimbursed Amount Related party transaction, reimbursed amount Vineti Inc. Vineti Inc [Member] Professional and Contract Services Expense Consulting service amount Prepayment premium Debt Instrument Prepayment Premium Debt instrument prepayment premium. Segment Reporting Disclosure [Text Block] Segment Information General and Administrative Expense General and Administrative Expense, Total General and administrative Preferred Stock, Convertible, Conversion Price Preferred stock conversion price Two Thousand And Three Equity Incentive Plan Two Thousand And Three Equity Incentive Plan [Member] 2003 Equity Incentive Plan [Member] Subsequent Event [Table] Equity Distribution Agreement [Member] Equity distribution agreement. Equity Distribution Agreement [Member] Line of Credit Facility, Interest Rate During Period Interest rate Schedule of Warrant Activity [Table Text Block] Schedule of warrant activity. Summary of Warrant Activity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Term A Tranche [Member] Term A Tranche [Member] Term A Tranche [Member] Consulting Services [Member] Consulting services. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, Minimum Depreciation Depreciation, Total Depreciation Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized compensation costs related to unvested restricted stock outstanding Eden Bio Cell [Member] Eden Bio Cell Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Series A-1 Preferred Stock Series A One Preferred Stock [Member] Series A one preferred stock. Series A-1 Preferred Stock [Member] Document Transition Report Operating Expenses Total operating expenses Commitments and Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Research and Development Expense Research and development Research and Development Expense, Total Research and development expense Series A - 1 Preferred Stock Series A-1 Preferred Stock [Member] Series A-1 preferred stock. Series A - 1 Preferred Stock [Member] Statement of Cash Flows [Abstract] Stock Issued During Period, Value, New Issues Aggregate offering price Issuance of common stock in registered direct offering, net of offering cost Minimum stockholders' equity requirement Share-Based Payment Arrangement, Option, Activity [Table Text Block] Stock Option Activity under Stock Option Plan Equity [Text Block] Equity Earnings Per Share [Text Block] Net earnings per share Collaboration agreement with solasia pharma K.K. Collaboration Agreement With Solasia Pharma KK [Member] Collaboration Agreement with Solasia Pharma KK [Member] Net loss Net loss Share - Based Compensation Arrangement by Share - Based Payment Award , Options , Vested in Period , Exercise Price Share based compensation arrangement by share based payment award options vested in period exercise price . Fully vested stock options at exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding, at end of period Warrants and Rights Outstanding, Term Weighted- Average Contractual Term (Years) Expected Term Preferred Stock, Convertible, Shares Issuable Convertible preferred stock designated shares Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Fair Value Assumptions Expected Dividend Rate ASSETS: Assets [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Document Fiscal Year Focus Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Fully vested stock options with aggregate fair value Research and Development Expense [Member] Research and Development [Member] Research and Development [Member] Subsidiary or Equity Method Investee, Sale of Stock [Table] Ziopharm [Member] Ziopharm [Member] Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Net loss applicable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to common stockholders Debt Instrument [Axis] Share-Based Payment Arrangement [Abstract] Derivative Liabilities Derivatives, Policy [Policy Text Block] Equity Method Investments and Joint Ventures Disclosure [Text Block] Joint Venture Title of 12(b) Security Equity milestone. Equity Milestone [Member] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled Related and Nonrelated Parties [Domain] Related Party [Domain] Percentage of prepayments premium Percentage Of Prepayments Premium Percentage of prepayments premium. Collaborative Arrangement and Arrangement Other than Collaborative [Table] Zero Milestone [Member] Zero Milestone [Member] Debt Instrument, Redemption, Period [Domain] Consolidated Entities [Axis] Legal Entity [Axis] Legal Entity [Axis] Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Ending Balance Beginning Balance Outside two thousand twelve plan [Member] Outside Two Thousand Twelve Plan [Member] Outside 2012 Plan Silicon Valley Bank loan. Silicon Valley Bank Loan [Member] Silicon Valley Bank Loan [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Shares issued as consideration for board service fees Stock Issued During Period, Value, Issued for Services Grant date fair value Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Statement of Income Location, Balance [Axis] Income Statement Location [Axis] Trading Symbol Stock Issued During Period, Value, Issued as Consideration for Services Stock issued during period value issued as consideration for services. Shares issued as consideration for services Term loan member Term Loan [Member] Term Loan [Member] Related Party Transaction [Table] Schedule of Related Party Transactions, by Related Party [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, Maximum Debt Instrument Redemption Period Three Member Debt Instrument, Redemption, Period Three [Member] Subsequent Event Type [Axis] Expected life in years Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Fair Value Assumptions Expected Term1 Fair Value, Recurring [Member] Fair Value, Measurements, Recurring [Member] Agreement Settlement Periodic Payment Agreement settlement periodic payment. Periodic payment for agreement settlement Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Two Thousand And Twelve Equity Incentive Plan Two Thousand And Twelve Equity Incentive Plan [Member] 2012 Equity Incentive Plan [Member] Non Vested Restricted Stock Non Vested Restricted Stock [Member] Unvested Restricted Common Stock Non Vested Restricted Stock [Member] Maximum [Member] Maximum [Member] Statistical Measurement [Axis] Range [Axis] Receivables Receivables, Net, Current Receivables, Net, Current, Total Common Stock, Value, Issued Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common stock aggregate fair value Common stock $0.001 par value; 50,000,000 shares authorized, 2,378,383 and 2,349,480 shares issued and outstanding at March 31, 2026 and at December 31, 2025, respectively Royalty [Member] Royalty [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Preferred Stock, Shares Authorized Preferred stock, shares authorized Lender Name [Axis] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Entity Registrant Name Debt Disclosure [Text Block] Debt Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Other income, net Subsequent Events [Abstract] Banking and Thrift, Interest [Abstract] Consolidated Entities [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Stockholders' Equity Deficiency Notice [Policy Text Block] Stockholders' Equity Deficiency Notice. Nasdaq Stockholders' Equity Deficiency Notice The University of Texas MD Anderson Cancer Center [Member] The University of Texas MD Anderson Cancer Center. Net proceeds Net Proceeds From Issuance of Common Stock and Pre Funded Warrents Net proceeds from issuance of common stock and pre funded warrents. Assets Total assets Sale Of Series A two Preferred Stock Value Sale of series a two preferred stock value. Sale of Series A-2 preferred stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Options exercisable, at end of period Income Statement [Abstract] Exercise Of Prefunded Warrants Shares Exercise of prefunded warrants shares. Exercise of prefunded warrants Debt Instrument Redemption Period One Debt Instrument, Redemption, Period One [Member] Additional number of warrants issued. Additional Number Of Warrants Issued Additional number warrants issued Stock Issued During Period, Shares, New Issues Common stock issuance Issuance of common stock in registered direct offering, net of offering cost (in shares) Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Earnings per share, Diluted Title and Position [Domain] Relationship to Entity [Domain] City Area Code Laboratory Equipment [Member] Laboratory Equipment [Member] Laboratory equipment [Member] Commitments and Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Line Items] Accrued Payments Defined Benefit Plan [Table] License Agreement Terms [Member] Cumulative preferred dividends Preferred Stock Dividends and Other Adjustments Preferred Stock Dividends and Other Adjustments, Total Cumulative preferred dividends Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Total Property and equipment, net Number of stock options granted and fully vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Operating Income (Loss) Loss from operations Loss from operations Interest expense amortized date. Interest Expense Amortized Date Interest expense amortized date Retained Earnings [Member] Accumulated Deficit Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation expense Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member] Class of Stock [Line Items] Secured Debt Secured Debt [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss Per Share Entity Interactive Data Current Statement of Income Location, Balance [Domain] Income Statement Location [Domain] Fees and Expenses, Related Party Costs and Expenses, Related Party Warrants expiration date Warrants Expiration Date Warrants Expiration Date Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities: Stock Issued During Period, Shares, Issued for Services Shares issued as consideration for board service fees ( in shares) Percentage of original principal due as a final payment Percentage of Original Principal Due as a Final Payment Percentage of original principal due as a final payment. Entity Tax Identification Number Issuance of prefunded warrants in registered direct offering Issuance Of Prefunded Warrants In Registered Direct Offering Value Issuance of prefunded warrants in registered direct offering avlue. Cash proceeds from sale of equity Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity, Total Local Phone Number Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Beginning Balance Stock option to purchase shares Reclassification Of Warrant Liability To Equity Value Reclassification of warrant liability to equity value. Reclassification of Warrant Liability to equity Warrants The entire disclosure pertaining to the warrant. Warrant [Text Block] Accounting Policies [Abstract] Series A One and Series A Two Convertible Preferred Stock [Member] Series A one and series A two convertible preferred stock. Series A-1and Series A-2 Convertible Preferred Stock Collaboration revenue Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer, Excluding Assessed Tax, Total Revenue Class of Stock [Domain] Class of Stock [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Options available for future grant Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected recognition period Stock, Class of Stock [Table] Schedule of Stock by Class [Table] Entity Emerging Growth Company